abstract |
The present invention relates to a probiotic medicine for treating diseases. The present invention provides a monoclonal antibody specific for MAdCAM-1, which can specifically bind to MAdCAM-1 to block the interaction between α4β7 and MAdCAM-1 to treat ulcerative colitis. Adding probiotics can synergistically promote the corresponding therapeutic effect, and has a good application prospect. |